Affimed (NASDAQ: AFMD) reported Q2 EPS of EUR(0.24), $0.01 worse than the analyst estimate of EUR(0.23). Revenue for the quarter came in at EUR2.07 million versus the consensus estimate of EUR1.42 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.